Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

Clinical trial NCT04501497 · COMPLETED

Trial details

NCT number: NCT04501497
Sponsor: Chugai Pharmaceutical
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer Extensive Disease Small Cell Lung Cancer

Start date: 2020-08-21
Primary completion: 2023-02-03
Enrollment: 1221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.